MSLN and pancreatic adenocarcinoma: As shown in Figure 9, compared with normal tissues, the expression levels of MET, DYNLL2, CDK1, TNFSF10, PIP5K1C, MSLN, and GKN1 were significantly increased in pancreatic adenocarcinoma cells (p < 0.05).